Autolus Therapeutics Trading Update
- Trading performance – Autolus Therapeutics (AUTL) closed 24 hours ago down 2.41 % at 02:44 AM Central Europe on Saturday 24 th.
- Current price – One share trades at approximately USD 1.54 on major exchanges.
- Market data –
- Shares outstanding: 266.2 million.
- Market capitalization: USD 431.2 million.
- Volume in the last 24 hours: USD 3 million.
- Year‑to‑date change (since last month end): down 20.2 %.
- 200‑day simple moving average: USD 1.67.
- 52‑week high: USD 2.58 (19 August 2026).
- 52‑week low: USD 1.18 (27 March 2026).
Related Stocks – 24‑Hour Performance
| Ticker | Trade change | Current price | Market cap | PE (if available) |
|---|---|---|---|---|
| RKT.L (Reckitt Benckiser) | –1.59 % | GBX 5,536 | GBX 47.3 bn | 12.21 |
| VOD.L (Vodafone) | –0.67 % | GBX 118.2 | GBX 47.4 bn | – |
| MAY.L (Mayflower Acquisition) | 0 % | USD 9.38 | USD 466.5 mn | – |
| IAG.L (Airline) | +1.33 % | GBX 394.7 | GBX 31.6 bn | 7.96 |
| KNOP (Knot Offshore) | +0.6 % | USD 10.26 | USD 336.3 mn | 45.27 |
Company Overview
Autolus Therapeutics PLC is a London‑based biopharmaceutical firm focused on the development of cell‑based therapies for cancer treatment. The company operates throughout the United Kingdom and is publicly listed on the Nasdaq exchange. Autolus conducted its initial public offering on 22 June 2018. Further information can be found on the company’s website: www.autolus.com .